Search Results 2411-2420 of 16281 for Epilepsy (Partial Onset)
This is a safety and pharmacokinetics study of MK-4280 as monotherapy and in combination with pembrolizumab (MK-3475) in adults with metastatic solid tumors for ...
The once-nightly dosing regimen may also provide enhanced convenience and compliance. In a previous clinical study, ADS-5102 met its primary endpoint; LID was ...
Copanlisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as nivolumab, may interfere ...
During the early ... There are also less common very early (phase 0) and later (phase 4) phases. ... History of a seizure disorder, dementia, cerebellar disease or ...
There are also less common very early (phase 0) and later (phase 4) phases. ... duration of the study. Subjects who have taken, or are expected to be ...
Find out about the challenges of not being able to get pregnant. Learn the causes, risk factors, and treatments including insemination and in vitro ...
History of epilepsy. Pregnant. Present of ferromagnet objects or non-MR-safe medical devices or implants. Note: Other protocol defined Inclusion/Exclusion ...
The purpose of this study is to understand the role of systemic inflammation in the genesis of seizures in susceptible children by gaining a clearer ...
... Epilepsy, Glioma, Carotid artery disease, Dural arteriovenous fistula, Brain AVM, Trigeminal neuralgia, Hydrocephalus, CSF leak, Astrocytoma, Brain lymphoma ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.